Go to the list of all blogs
published in Blogs
Sep 08, 2026
Southwest Airlines (LUV) Drops -17% Over 30 Days on Fuel Headwinds and Guidance

Southwest Airlines (LUV) Drops -17% Over 30 Days on Fuel Headwinds and Guidance

Key Takeaways

  • Southwest Airlines (LUV) shares fell roughly 17% over the last 30 days, from about $47.05 per share to near $39.
  • The decline followed a July 22 earnings report in which strong second-quarter results were overshadowed by softer third-quarter guidance and a lowered full-year profit outlook.
  • Surging jet-fuel costs tied to renewed Middle East conflict remain the central earnings headwind, offsetting strong revenue and pricing gains.
  • The multi-month trend has been volatile: a sharp rally toward $52 in late June gave way to a sustained pullback through July and August.
  • Business-transformation initiatives are gaining traction but have not yet fully neutralized the fuel-driven pressure on margins.

Company Background and Market Position

Southwest Airlines is one of the largest U.S. carriers and the biggest domestic airline by passengers boarded. The Dallas-based operator runs a point-to-point network with high-frequency, short- to medium-haul routes and an all-Boeing 737 fleet of roughly 800 aircraft. I follow LUV because of its scale and direct exposure to U.S. consumer demand, plus the ongoing transformation aimed at improving profitability. Recent moves include assigned seating, extra-legroom options, basic economy fares, checked-bag fees, a refreshed loyalty program, and a bigger push into managed business travel. The company also keeps an investment-grade balance sheet and returns capital via dividends and buybacks.

Recent Stock Performance: 30 Days and the Broader Quarter

Over the last 30 days, LUV declined approximately 17%, moving from about $47.05 per share down to roughly $39. The path was uneven, with an initial slide after the July 22 earnings report, a brief rebound in early August on fleet and product updates, then further weakness into September. The three-month view is more mixed. Shares climbed from near $41 in early June to a late-June peak above $52 before giving back most of those gains and finishing the period roughly 5% lower. In short, the 30-day drop forms a sharp leg within a longer, volatile unwind from the June highs.

Key Drivers Behind the 30-Day Move

The main catalyst was the second-quarter report released on July 22. The company posted record revenue and a solid earnings beat—adjusted EPS of $0.94 versus consensus near $0.51—yet lowered its full-year 2026 adjusted EPS outlook to $3.25–$4.25 from a prior “at least $4.00” target and guided third-quarter earnings of $0.50–$0.75, below the roughly $0.80–$0.82 analysts expected. Shares fell more than 6% the next session. Fuel costs stand out as the chief issue. Jet-fuel expenses rose sharply after renewed Middle East conflict, with quarterly fuel costs up about 67% year over year to roughly $2.22 billion—a headwind management sized at about $1.17 per share. Higher average fares, up roughly 21%, and a roughly 20% gain in unit revenue provided some offset but did not fully neutralize the pressure. In early August, FAA certification of the Boeing 737-7 (a launch customer for Southwest) and the rollout of a new “Business Priority” product offered brief support, but the rebound faded as fuel concerns lingered and the broader airline sector stayed under pressure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Quarterly Context and Underlying Business Trends

The quarterly story shows rising revenue momentum running into an industry-wide fuel shock. Through June, investors rewarded accelerating unit-revenue growth and the shift toward a higher-margin model, lifting the stock above $50. That optimism cooled once management trimmed its full-year profit floor because of the forward fuel curve. Under the surface, the business continues to improve: managed-business revenue grew 30% year over year, loyalty enrollment and co-brand card acquisitions rose sharply, and operating margins expanded. Because fuel ranks among the largest variable costs, the earnings benefit of pricing and product initiatives has been partly masked, leaving the stock sensitive to energy markets and geopolitical developments. From what I see, this dynamic explains much of the recent volatility.

Factors to Watch Going Forward

Several items will likely influence LUV in the months ahead. Fuel costs remain the biggest variable: Southwest has assumed third-quarter fuel of $3.70–$3.75 per gallon, and any further rise in oil prices or escalation in the Middle East could weigh directly on results. Investors should track the pace of revenue transformation, especially adoption of assigned seating, extra-legroom options, basic economy fares, and corporate-travel products, and whether those steps can sustain high-teens unit-revenue growth. Fleet updates, including the timing of Boeing 737-7 and 737-8 deliveries, also matter. Finally, full-year guidance of $3.25–$4.25 in adjusted EPS, capacity growth near 1.5%, and broader U.S. consumer demand plus competitor capacity decisions will help shape how the market views the stock in coming quarters. I’m watching this closely with an eye on how the transformation initiatives interact with energy markets.

Exploring AI Tools in My Research Process

When analyzing names like LUV, I sometimes turn to Tickeron’s AI Trading Bots to test different automated strategies and see how they align with the current setup. The platform surfaces top-performing bots from a broad universe, allowing quick comparisons across risk levels and timeframes. It serves as a useful complement to traditional research without replacing it. In my view, these tools help surface patterns that might otherwise be missed in fast-moving sectors like airlines.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LUV

LUV's RSI Oscillator ascends from oversold territory

The RSI Oscillator for LUV moved out of oversold territory on September 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 25 of the 32 cases the stock moved higher. This puts the odds of a move higher at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on LUV as a result. In 66 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for LUV just turned positive on September 09, 2026. Looking at past instances where LUV's MACD turned positive, the stock continued to rise in 36 of 53 cases over the following month. The odds of a continued upward trend are 68%.

Following a +1.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where LUV advanced for three days, in 218 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

The Aroon Indicator entered an Uptrend today. In 143 of 207 cases where LUV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 57 cases where LUV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

LUV moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for LUV moved below the 200-day moving average on September 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

LUV broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.921) is normal, around the industry mean (3.112). P/E Ratio (26.425) is within average values for comparable stocks, (23.433). Projected Growth (PEG Ratio) (0.200) is also within normal values, averaging (2.252). Dividend Yield (0.017) settles around the average of (0.010) among similar stocks. P/S Ratio (0.683) is also within normal values, averaging (0.529).

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. LUV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

Notable companies

The most notable companies in this group are Delta Air Lines (NYSE:DAL), United Airlines Holdings (NASDAQ:UAL), Southwest Airlines Co (NYSE:LUV), American Airlines Group (NASDAQ:AAL), JetBlue Airways Corp (NASDAQ:JBLU).

Industry description

Airlines industry comprises passenger air transportation, including scheduled and non-scheduled routes. This can include charter airlines, as well as regular commuter ones. Discount pricing and the rise of low-cost carriers over recent decades have expanded the industry by making its services accessible to a much larger global population, compared to the older days when airline travel was a relative luxury for many people in the world. Delta Air Lines Inc., Southwest Airlines Co and United Continental Holdings, Inc. are some of the airlines with the largest stock market capitalizations in the U.S.

Market Cap

The average market capitalization across the Airlines Industry is 10.42B. The market cap for tickers in the group ranges from 384.9K to 1.51T. AZULD holds the highest valuation in this group at 1.51T. The lowest valued company is AIBEF at 384.9K.

High and low price notable news

The average weekly price growth across all stocks in the Airlines Industry was -1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 2%. AZUL experienced the highest price growth at 9%, while SRFM experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Airlines Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -66%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 51
Price Growth Rating: 53
SMR Rating: 66
Profit Risk Rating: 73
Seasonality Score: 32 (-100 ... +100)
View a ticker or compare two or three
LUV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of scheduled air transportation services

Industry Airlines

Industry
Airlines
Address
P.O. Box 36611
Phone
+1 214 792-4000
Employees
72790
Web
https://www.southwest.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.